Localized prostate cancer: brachytherapy

Current Treatment Options in Oncology

Volumn 3, Issue 5, 2002, Pages 429-436

  Zietman, Anthony L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

External Beam; Prostate Cancer; Prostate Volume; Radiat Oncol Biol Phys; Radical Prostatectomy

Indexed keywords

BRACHYTHERAPY; HUMAN; MALE; METHODOLOGY; PROSTATE TUMOR; REVIEW;

BRACHYTHERAPY; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 0036781496     PISSN: 15272729     EISSN: 15346277     Source Type: Journal    
DOI: 10.1007/s11864-002-0007-2     Document Type: Article

References (28)

1. Fowler FJ, Collins MN, Albertsen PC, et al.: A comparison of the treatment recommendations for men with clinically localized prostate cancer by urologists and radiation oncologists. JAMA 2000, 283:3217–3222. DOI: 10.1001/jama.283.24.3217
2. Zietman AL, Moughan J, Owen J, Hanks GE: The Patterns of Care Survey of radiation therapy in localized prostate cancer: similarities between the practice nationally and in minority-rich areas. Int J Radiat Oncol Biol Phys 2001, 50:75–80. DOI: 10.1016/S0360-3016(00)01569-8
3. Waterman FM, Yue N, Corn BW, Dicker AP: Edema associated with I-125 of PD-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition. Int J Radiat Oncol Biol Phys 1998, 41: 1069–1077. DOI: 10.1016/S0360-3016(98)00152-7
4. Stock RG, Stone NN, Tabert A, et al. A dose-response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys 1998, 41: 101–108. DOI: 10.1016/S0360-3016(98)00006-6
5. Lee WR, deGuzman AF, Bare RL, et al. Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: evidence for a learning curve in the first year at a single institution. Int J Radiat Oncol Biol Phys 2000, 46:83–88. DOI: 10.1016/S0360-3016(99)00359-4
6. Sharkey J, Chovnick SD, Behar RJ, et al. Outpatient ultrasound-guided palladium 103 brachytherapy for localized adenocarcinoma of the prostate: a preliminary report of 434 patients. Urology 1998, 61: 796–803. DOI: 10.1016/S0090-4295(98)00017-X
7. D’Amico AV, Cormack R, Tempany CM, et al. Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1998, 42:507–515. DOI: 10.1016/S0360-3016(98)00271-5
8. Chen ME, Johnston DA, Tang K, et al. Detailed mapping of prostate carcinoma foci. Cancer 2000, 89:1800–1809. DOI: 10.1002/1097-0142(20001015)89:8<1800::AID-CNCR21>3.0.CO;2-D
9. D’Amico AV, Davis A, Vargas SO, et al. Defining the implant treatment volume for patients with low risk prostate cancer: does the anterior base need to be treated? Int J Radiat Oncol Biol Phys 1999, 43:587–590. DOI: 10.1016/S0360-3016(98)00434-9
10. D’Amico AV, Whittington R, Malkowicz B, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinical localized prostate cancer. JAMA 1998, 280:969–974. DOI: 10.1001/jama.280.11.969
11. Bellon J, Wallner K, Ellis W, et al. Use of pelvic CT scanning to evaluate pubic arch interference of transperineal prostate brachytherapy. Int J Radiat Oncol Biol Phys 1999, 43:579–581. DOI: 10.1016/S0360-3016(98)00466-0
12. Kucway R, Vicini F, Huang R, et al. Prostate volume reduction with androgen deprivation before interstitial brachytherapy. J Urol 2002, 167:2443–2447. DOI: 10.1016/S0022-5347(05)65001-X
13. Sylvester JE, Blasko KC, Grimm PD, Cavanagh WA: 125- Iodine/103 palladium brachytherapy with or without neoadjuvant androgen ablation for early stage prostate cancer. Int J Radiat Oncol Biol Phys 2000, 48:310–311. DOI: 10.1016/S0360-3016(00)80423-X
14. Talcott JA, Clark JA, Stark PC, Mitchell SP: Long-term treatment complications of brachytherapy for early prostate cancer: a survey of patients previously treated. J Urol 2001, 166:494–499. DOI: 10.1016/S0022-5347(05)65970-8
15. Hu K, Wallner K: Urinary incontinence in patients who have a TRUP/TUIP following prostate brachytherapy. Int J Radiat Oncol Biol Phys 1998, 40:783–786. DOI: 10.1016/S0360-3016(97)00928-0
16. Brandeis JM, Litwin MS, Burnison CM, Reiter RE: Quality of life outcomes after brachytherapy for early stage prostate cancer. J Urol 2000, 163:851–857. DOI: 10.1016/S0022-5347(05)67818-4
17. Hu K, Wallner K: Clinical course of rectal bleeding following I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 1998, 41: 263–265. DOI: 10.1016/S0360-3016(98)00080-7
18. Blasko JC, Grimm PD, Sylvester JE, et al. Palladium-103 brachytherapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 2000, 46:839–850. DOI: 10.1016/S0360-3016(99)00499-X
19. Ragde H, Elgamal AA, Snow PB, et al. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma. Cancer 1998, 83:989–1001. DOI: 10.1002/(SICI)1097-0142(19980901)83:5<989::AID-CNCR26>3.0.CO;2-Q
20. Potters L, Oshinsky G, Zelefsky M, Leibel S: Risk profiles to predict PSA relapse-free survival for patients undergoing permanent prostate brachytherapy. Cancer J Sci Am 1999, 5:301–306.
21. Storey MR, Landgren RC, Cottone JL, et al. Transperineal 125Iodine implantation for treatment of clinically localized prostate cancer: 5-year tumor control and morbidity. Int J Radiat Oncol Biol Phys 1999, 443:565–570. DOI: 10.1016/S0360-3016(98)00451-9
22. Zelefsky MJ, Fuks Z, Hunt M, et al. High dose radiation delivered by intensity modulated conformal radio-therapy improves the outcome of localized prostate cancer. J Urol 2001, 166:876–881. DOI: 10.1016/S0022-5347(05)65855-7
23. Catalona WJ, Smith DS: Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results. J Urol 1998, 160:2428–2452. DOI: 10.1016/S0022-5347(01)62204-3
24. Pound CR, Partin AW, Epstein JI, Walsh PC: Prostate specific antigen after anatomic radical retropubic prostatectomy. Urol Clin North Am 1997, 24:395–402. DOI: 10.1016/S0094-0143(05)70386-4
25. Brandeis J, Pashos CL, Henning JM, Litwin MS: A nationwide charge comparison of the principal treatments for early stage prostate carcinoma. Cancer 2000, 89:1792–1799. DOI: 10.1002/1097-0142(20001015)89:8<1792::AID-CNCR20>3.0.CO;2-4
26. Critz FA, Williams WH, Levinson K, et al. Simultaneous irradiation for prostate cancer: intermediate results with modern techniques. J Urol 2000, 164:738–742. DOI: 10.1016/S0022-5347(05)67293-X
27. Martinez AA, Gustafson G, Gonzalez J, et al. Dose escalation using conformal high-dose rate brachytherapy improves outcomes in unfavorable prostate cancer. Int J Radiat Oncol Biol Phys 2002, 53:316–327. DOI: 10.1016/S0360-3016(02)02733-5
28. Kestin LL, Martinez AA, Stromberg JS, et al. Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer. J Clin Oncol 2000, 18:2869–2880.